A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848

Clinical trial NCT00743860 · COMPLETED

Trial details

NCT number: NCT00743860
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2008-09-01
Primary completion: 2008-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.